*
Corresponding authors
a
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China
E-mail:
pirb@mail.sysu.edu.cn
b
International Joint Laboratory (SYSU-PolyU HK) of Novel Anti-Dementia Drugs of Guangdong, Guangzhou 510006, China
c
National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Sun Yat-sen University, Guangzhou 510006, China
d
Institute of Chemistry, University of Tartu, Ravila St., Tartu 50411, Estonia
e
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng East Road, Guangzhou 510060, China
f
Department of Neurology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
g
Guangdong Province Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China